For the typical contract packager, high-volume drugs are given scheduling priority; low-volume jobs are slotted as gaps become available between larger projects. This common practice makes it challenging to find timely and predictable commercial packaging for low-volume products. For patients for whom the drug in question may be the only therapeutic option available, any delay in packaging that results in a market shortage can have serious consequences.
Companies with orphan, niche, and low-volume drug products have options other than large-scale contract manufacturing services. This webcast will describe one solution: Working with a clinical supply partner to handle the packaging and potential complex distribution logistics for expanded access programs and commercial supply.
| Register now |
Unable to attend? All registrants receive a link to a recorded version of the webcast.
